Germany hands back royal-era artefacts to Ethiopia
Germany has returned 12 royal-era cultural artefacts to Ethiopia in a ceremony in Addis Ababa, marking a formal step in ongoing cultural cooperation b...
Scientists in the UK have developed a super-strong antibody that could dramatically improve how the immune system attacks cancer cells by boosting its activation power.
Researchers at the University of Southampton have designed a new type of antibody that could strengthen the immune system’s ability to fight cancer. The team, supported by Cancer Research UK, discovered that by increasing the rigidity of antibodies - tiny proteins produced by white blood cells - they could trigger a much stronger immune response.
Antibodies work by attaching to harmful cells like bacteria, viruses, or cancer cells, marking them for attack by the immune system. The new prototype, which features extra structural bonds to stiffen its Y-shaped form, was found to outperform naturally occurring antibodies in lab tests.
“The concept of using immuno-stimulation for cancer treatment is very exciting,” said Professor Mark Cragg of the Centre for Cancer Immunology. “Even small increases in rigidity significantly improve how well antibodies can activate the immune system.”
Using supercomputers, the team visualized antibodies at atomic detail to precisely insert additional disulfide bonds—tiny bridges that stabilize the structure. This made the antibodies more rigid, allowing them to hold immune receptors closer together and produce a stronger activation signal.
PhD student Isabel Elliott explained: “Floppier antibodies are less effective at triggering immune cells. Rigid ones seem to organize the receptors better, leading to a more powerful response.”
Dr. Ivo Tews, Professor in Structural Biology, added that this strategy could be applied to a wide range of immune-related molecules, not just those used in cancer therapy.
Dr. Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK, emphasized the potential impact of the findings: “Refining how we harness the immune system is a vital step forward. These super-strong antibodies could empower new, more effective treatments for patients undergoing immunotherapy.”
The research is published in the journal Nature Communications, marking a promising step toward next-generation cancer treatments designed to supercharge the body’s natural defenses.
Thousands of users in the United States, some parts of Europe and South America on the X (formerly twitter) platform have reported being unable to access the site due to Cloudflare outage.
Emirates Airline is confident in Boeing’s plans for a larger 777X and has ruled out ordering Airbus’s A350-1000 at the Dubai Airshow.
Punjab’s modern political story begins in 1947. The end of British rule divided the region between India and Pakistan, leaving Sikh communities with a split homeland and unresolved questions about cultural and administrative protections.
Iran's air force, heavily reliant on aging F-14A Tomcat jets, faces a growing technological gap as its neighbors rapidly modernize their air forces with advanced fighter jets and air defense systems.
China's Foreign Minister Wang Yi on Tuesday talked up "high-level exchanges" in a call with Japanese counterpart Toshimitsu Motegi, hinting at a potential meeting between Chinese President Xi Jinping and Japan's new premier, Sanae Takaichi.
Audi has unveiled the car that marks its first major step into Formula One. It presented the 2026 challenger at a launch event in Munich attended by drivers, team leaders and senior company executives.
Billionaire Jeff Bezos’s Blue Origin has launched NASA’s twin ESCAPADE satellites to Mars on Sunday, marking the second flight of its New Glenn rocket, a mission seen as a crucial test of the company’s reusability ambitions and a fresh challenge to Elon Musk’s SpaceX.
China has announced exemptions to its export controls on Nexperia chips intended for civilian use, the commerce ministry said on Sunday, a move aimed at easing supply shortages affecting carmakers and automotive suppliers.
Nobel Prize-winning scientist James Watson, who co-discovered the DNA double-helix structure, has died at 97, his former research lab confirmed.
As competition over artificial intelligence intensifies, U.S. tech leaders are warning that China’s rapid state-backed progress could soon outpace the West, raising concerns that America is losing its technological edge.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment